Deer­field strikes up new deal with Co­lum­bia Uni­ver­si­ty; Ovid CEO Je­re­my Levin joins BIO as new board chair

→ In its lat­est deal, health­care in­vest­ment firm Deer­field Man­age­ment and Co­lum­bia Uni­ver­si­ty have col­lab­o­rat­ed to launch Hud­son Heights In­no­va­tions “to cat­alyze the de­vel­op­ment of nov­el ther­a­peu­tics out of the re­search labs of Co­lum­bia Uni­ver­si­ty”. Deer­field and its part­ners will pro­vide up to $130 mil­lion in ini­tial fund­ing to back the ini­tia­tive for over 10 years. 

“Much of our re­search is aimed at un­der­stand­ing at the mol­e­c­u­lar lev­el how dis­eases de­vel­op and how we can in­ter­vene with drugs or oth­er ther­a­peu­tics,” said Lee Gold­man, dean of the fac­ul­ties of health sci­ences and med­i­cine and chief ex­ec­u­tive of Co­lum­bia Uni­ver­si­ty Irv­ing Med­ical Cen­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER